[{"id":5458,"run_id":242,"as_of":"2026-08-22","ticker":"PRQR","company":"Proqr Therapeutics N.V.","source":"weekly","conviction":50.7,"technical":52.1,"stage":"Regime Shift","gated":true,"n_gates":2,"gates":["200DMA is not rising — regime not clear.","Price $2.34 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.34,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":12.9,"Volatility behaviour":5.8,"Cross-asset confirmation":15.6,"Sponsorship / positioning":7.4,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":1342385.0,"n_cfo_buys":0.0,"n_other_buys":5.0,"has_cfo_buy":false,"roles_buying":"3 CEO, 2 Director","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-22T14:49:55.536534+00:00"},{"id":5551,"run_id":256,"as_of":"2026-08-24","ticker":"PRQR","company":"Proqr Therapeutics N.V.","source":"weekly","conviction":50.3,"technical":51.6,"stage":"Regime Shift","gated":true,"n_gates":2,"gates":["200DMA is not rising — regime not clear.","Price $2.43 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.43,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":13.2,"Volatility behaviour":5.8,"Cross-asset confirmation":14.7,"Sponsorship / positioning":7.6,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":1342385.0,"n_cfo_buys":0.0,"n_other_buys":5.0,"has_cfo_buy":false,"roles_buying":"3 CEO, 2 Director","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-24T13:43:37.609921+00:00"},{"id":6261,"run_id":270,"as_of":"2026-08-25","ticker":"PRQR","company":"Proqr Therapeutics N.V.","source":"weekly","conviction":50.6,"technical":52.0,"stage":"Regime Shift","gated":true,"n_gates":2,"gates":["200DMA is not rising — regime not clear.","Price $2.38 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.38,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":12.8,"Volatility behaviour":5.8,"Cross-asset confirmation":15.3,"Sponsorship / positioning":7.7,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":1342385.0,"n_cfo_buys":0.0,"n_other_buys":5.0,"has_cfo_buy":false,"roles_buying":"3 CEO, 2 Director","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-25T16:51:35.628977+00:00"},{"id":7022,"run_id":309,"as_of":"2026-08-26","ticker":"PRQR","company":"Proqr Therapeutics N.V.","source":"weekly","conviction":52.2,"technical":54.0,"stage":"Regime Shift","gated":true,"n_gates":2,"gates":["200DMA is not rising — regime not clear.","Price $2.35 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.35,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":13.6,"Volatility behaviour":12.5,"Cross-asset confirmation":15.2,"Sponsorship / positioning":1.9,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":1342385.0,"n_cfo_buys":0.0,"n_other_buys":5.0,"has_cfo_buy":false,"roles_buying":"3 CEO, 2 Director","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-26T20:44:22.189017+00:00"},{"id":7754,"run_id":390,"as_of":"2026-08-27","ticker":"PRQR","company":"Proqr Therapeutics N.V.","source":"weekly","conviction":50.8,"technical":52.2,"stage":"Regime Shift","gated":true,"n_gates":2,"gates":["200DMA is not rising — regime not clear.","Price $2.32 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.32,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":13.2,"Volatility behaviour":12.5,"Cross-asset confirmation":14.2,"Sponsorship / positioning":1.9,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":1342385.0,"n_cfo_buys":0.0,"n_other_buys":5.0,"has_cfo_buy":false,"roles_buying":"3 CEO, 2 Director","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-27T20:17:55.852107+00:00"},{"id":8380,"run_id":411,"as_of":"2026-08-28","ticker":"PRQR","company":"Proqr Therapeutics N.V.","source":"weekly","conviction":50.7,"technical":52.1,"stage":"Regime Shift","gated":true,"n_gates":2,"gates":["200DMA is not rising — regime not clear.","Price $2.32 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.32,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":13.2,"Volatility behaviour":12.5,"Cross-asset confirmation":14.1,"Sponsorship / positioning":1.9,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":1342385.0,"n_cfo_buys":0.0,"n_other_buys":5.0,"has_cfo_buy":false,"roles_buying":"3 CEO, 2 Director","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-29T11:54:20.316176+00:00"},{"id":8984,"run_id":413,"as_of":"2026-08-30","ticker":"PRQR","company":"Proqr Therapeutics N.V.","source":"weekly","conviction":49.6,"technical":50.8,"stage":"Regime Shift","gated":true,"n_gates":2,"gates":["200DMA is not rising — regime not clear.","Price $2.29 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.29,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":13.1,"Volatility behaviour":12.5,"Cross-asset confirmation":13.0,"Sponsorship / positioning":2.0,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":1342385.0,"n_cfo_buys":0.0,"n_other_buys":5.0,"has_cfo_buy":false,"roles_buying":"3 CEO, 2 Director","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-30T01:15:14.903614+00:00"},{"id":9075,"run_id":414,"as_of":"2026-08-31","ticker":"PRQR","company":"Proqr Therapeutics N.V.","source":"weekly","conviction":56.0,"technical":58.8,"stage":"Regime Shift","gated":true,"n_gates":3,"gates":["200DMA is not rising — regime not clear.","Overlapping range behaviour — efficiency ratio 0.14 vs the 0.15 threshold (borderline, watch for resolution).","Price $2.13 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.13,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":12.0,"Volatility behaviour":12.4,"Cross-asset confirmation":13.5,"Sponsorship / positioning":9.1,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":1342385.0,"n_cfo_buys":0.0,"n_other_buys":5.0,"has_cfo_buy":false,"roles_buying":"3 CEO, 2 Director","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-08-31T21:22:03.535773+00:00"},{"id":9671,"run_id":417,"as_of":"2026-09-01","ticker":"PRQR","company":"Proqr Therapeutics N.V.","source":"weekly","conviction":56.8,"technical":59.7,"stage":"Regime Shift","gated":true,"n_gates":3,"gates":["200DMA is not rising — regime not clear.","Market cap $299M below the $300M floor.","Price $2.12 below the $5.00 floor."],"sizing_low":0.0,"sizing_high":0.0,"sizing_label":"No trade / watch only","close":2.12,"sector":"Healthcare","etf":"XLV","pillars":{"Regime clarity":12.0,"Volatility behaviour":12.2,"Cross-asset confirmation":14.4,"Sponsorship / positioning":9.2,"Catalyst alignment (insider)":9.0},"total_cfo_value":0.0,"total_other_value":1342385.0,"n_cfo_buys":0.0,"n_other_buys":5.0,"has_cfo_buy":false,"roles_buying":"3 CEO, 2 Director","npr":1.0,"cluster_insiders":2.0,"days_since_buy":null,"insider_lookup_failed":false,"technical_only":false,"created_at":"2026-09-01T21:37:53.063049+00:00"}]